Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Jessica Fye is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/03/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/03/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $246.81 | 0.48% | $160 → $248 | Maintains | Neutral | Get Alert |
| 06/20/2024 | INSM | Buy Now | Insmed | $62.01 | 16.1% | $55 → $72 | Maintains | Overweight | Get Alert |
| 06/18/2024 | MIRM | Buy Now | Mirum Pharmaceuticals | $33.68 | 15.8% | $31 → $39 | Maintains | Overweight | Get Alert |
| 06/12/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $68.22 | 14.34% | $75 → $78 | Maintains | Overweight | Get Alert |
| 05/29/2024 | INSM | Buy Now | Insmed | $62.01 | -11.31% | $36 → $55 | Maintains | Overweight | Get Alert |
| 05/21/2024 | UTHR | Buy Now | United Therapeutics | $311.13 | -3.58% | $280 → $300 | Maintains | Overweight | Get Alert |
| 05/03/2024 | ASND | Buy Now | Ascendis Pharma | $135.44 | 25.52% | $167 → $170 | Maintains | Overweight | Get Alert |
| 04/02/2024 | ASND | Buy Now | Ascendis Pharma | $135.44 | 23.31% | $165 → $167 | Maintains | Overweight | Get Alert |
| 03/26/2024 | STOK | Buy Now | Stoke Therapeutics | $12.93 | 0.54% | $6 → $13 | Maintains | Neutral | Get Alert |
| 03/22/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $104.15 | 82.43% | $170 → $190 | Maintains | Overweight | Get Alert |
| 03/22/2024 | BNTX | Buy Now | BioNTech | $80.05 | 12.44% | $99 → $90 | Maintains | Underweight | Get Alert |
| 03/20/2024 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | $14 → $16 | Maintains | Neutral | Get Alert |
| 03/20/2024 | IMCR | Buy Now | Immunocore Hldgs | $36.12 | 93.83% | $60 → $70 | Maintains | Overweight | Get Alert |
| 03/19/2024 | BGNE | Buy Now | BeiGene | $146.77 | 26.73% | $184 → $186 | Maintains | Overweight | Get Alert |
| 03/19/2024 | NVCR | Buy Now | NovoCure | $16.71 | 1.74% | $15 → $17 | Maintains | Neutral | Get Alert |
| 02/29/2024 | JAZZ | Buy Now | Jazz Pharmaceuticals | $104.15 | 63.23% | $180 → $170 | Maintains | Overweight | Get Alert |
| 02/06/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $469.07 | -4.07% | $438 → $450 | Maintains | Overweight | Get Alert |
| 02/06/2024 | BGNE | Buy Now | BeiGene | $146.77 | 26.05% | → $185 | Assumes | → Overweight | Get Alert |
| 02/01/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $469.07 | -6.62% | $390 → $438 | Maintains | Overweight | Get Alert |
| 02/01/2024 | IONS | Buy Now | Ionis Pharmaceuticals | $44.59 | 23.35% | $52 → $55 | Maintains | Neutral | Get Alert |
| 12/28/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.90 | 10.02% | $25 → $45 | Maintains | Neutral | Get Alert |
| 12/28/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | $217 → $330 | Downgrade | Overweight → Neutral | Get Alert |
| 12/01/2023 | MRNA | Buy Now | Moderna | $116.22 | -22.56% | $93 → $90 | Maintains | Neutral | Get Alert |
| 12/01/2023 | BNTX | Buy Now | BioNTech | $80.05 | 23.68% | $106 → $99 | Downgrade | Neutral → Underweight | Get Alert |
| 11/20/2023 | NKTR | Buy Now | Nektar Therapeutics | $1.25 | — | — | Reinstates | → Underweight | Get Alert |
| 11/20/2023 | EBS | Buy Now | Emergent BioSolutions | $7.45 | — | — | Reinstates | → Underweight | Get Alert |
| 11/20/2023 | ESPR | Buy Now | Esperion Therapeutics | $2.35 | — | — | Reinstates | → Neutral | Get Alert |
| 11/20/2023 | AMRN | Buy Now | Amarin Corp | $0.70 | — | — | Reinstates | → Underweight | Get Alert |
| 11/20/2023 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | → $14 | Reinstates | → Neutral | Get Alert |
| 11/20/2023 | BCRX | Buy Now | BioCryst Pharma | $6.62 | 51.06% | → $10 | Reinstates | → Overweight | Get Alert |
| 11/20/2023 | MIRM | Buy Now | Mirum Pharmaceuticals | $33.68 | 9.86% | → $37 | Reinstates | → Overweight | Get Alert |
| 11/20/2023 | CRNX | Buy Now | Crinetics Pharmaceuticals | $45.09 | -22.38% | → $35 | Reinstates | → Overweight | Get Alert |
| 11/20/2023 | IMCR | Buy Now | Immunocore Hldgs | $36.12 | 66.14% | → $60 | Reinstates | → Overweight | Get Alert |
| 11/20/2023 | DNLI | Buy Now | Denali Therapeutics | $21.91 | 27.8% | → $28 | Reinstates | → Overweight | Get Alert |
| 11/20/2023 | INSM | Buy Now | Insmed | $62.01 | -41.95% | → $36 | Reinstates | → Overweight | Get Alert |
| 11/20/2023 | ALKS | Buy Now | Alkermes | $24.27 | 35.97% | → $33 | Reinstates | → Neutral | Get Alert |
| 11/20/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.90 | -38.88% | → $25 | Reinstates | → Neutral | Get Alert |
| 10/10/2023 | RYZB | Buy Now | RayzeBio | — | — | → $30 | Initiates | → Overweight | Get Alert |
| 06/05/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $68.22 | -9.12% | $58 → $62 | Maintains | Overweight | Get Alert |
| 05/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $469.07 | -26.45% | → $345 | Maintains | Overweight | Get Alert |
| 04/25/2023 | ALKS | Buy Now | Alkermes | $24.27 | 27.73% | $29 → $31 | Maintains | Neutral | Get Alert |
| 04/19/2023 | LEGN | Buy Now | Legend Biotech | $46.37 | 63.9% | $65 → $76 | Maintains | Overweight | Get Alert |
| 04/12/2023 | MRNA | Buy Now | Moderna | $116.22 | 20.46% | $145 → $140 | Maintains | Neutral | Get Alert |
| 04/10/2023 | BNTX | Buy Now | BioNTech | $80.05 | 59.91% | $142 → $128 | Maintains | Neutral | Get Alert |
| 04/10/2023 | MRNA | Buy Now | Moderna | $116.22 | 24.76% | $127 → $145 | Maintains | Neutral | Get Alert |
| 03/17/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.90 | -29.1% | $40 → $29 | Downgrade | Overweight → Neutral | Get Alert |
| 03/17/2023 | NVCR | Buy Now | NovoCure | $16.71 | 199.22% | $99 → $50 | Downgrade | Neutral → Underweight | Get Alert |
| 03/17/2023 | EBS | Buy Now | Emergent BioSolutions | $7.45 | 20.81% | $23 → $9 | Downgrade | Neutral → Underweight | Get Alert |
| 03/09/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $68.22 | -14.98% | $59 → $58 | Maintains | Overweight | Get Alert |
| 02/27/2023 | ESPR | Buy Now | Esperion Therapeutics | $2.35 | 282.98% | $8 → $9 | Maintains | Neutral | Get Alert |
| 02/23/2023 | HALO | Buy Now | Halozyme Therapeutics | $52.00 | — | $54 → $52 | Maintains | Overweight | Get Alert |
| 02/13/2023 | SGEN | Buy Now | Seagen | — | — | $154 → $150 | Maintains | Overweight | Get Alert |
| 02/08/2023 | INCY | Buy Now | Incyte | $57.95 | 38.05% | $82 → $80 | Maintains | Neutral | Get Alert |
| 02/08/2023 | BNTX | Buy Now | BioNTech | $80.05 | 77.4% | $148 → $142 | Maintains | Neutral | Get Alert |
| 02/08/2023 | MRNA | Buy Now | Moderna | $116.22 | 18.74% | $132 → $138 | Maintains | Neutral | Get Alert |
| 01/06/2023 | NVCR | Buy Now | NovoCure | $16.71 | 492.46% | $86 → $99 | Maintains | Neutral | Get Alert |
| 12/06/2022 | ALKS | Buy Now | Alkermes | $24.27 | 19.49% | $33 → $29 | Maintains | Neutral | Get Alert |
| 12/06/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.90 | -2.2% | $49 → $40 | Maintains | Overweight | Get Alert |
| 12/06/2022 | LEGN | Buy Now | Legend Biotech | $46.37 | 40.18% | $61 → $65 | Maintains | Overweight | Get Alert |
| 11/22/2022 | HALO | Buy Now | Halozyme Therapeutics | $52.00 | 3.85% | $53 → $54 | Maintains | Overweight | Get Alert |
| 11/03/2022 | UTHR | Buy Now | United Therapeutics | $311.13 | -14.83% | $240 → $265 | Maintains | Overweight | Get Alert |
| 10/25/2022 | TCDA | Buy Now | Tricida | — | — | — | Downgrade | Neutral → Underweight | Get Alert |
| 10/24/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $469.07 | -30.29% | $319 → $327 | Maintains | Overweight | Get Alert |
| 10/24/2022 | SGEN | Buy Now | Seagen | — | — | $194 → $155 | Maintains | Overweight | Get Alert |
| 10/24/2022 | MRNA | Buy Now | Moderna | $116.22 | 4.97% | $165 → $122 | Maintains | Neutral | Get Alert |
| 10/24/2022 | INCY | Buy Now | Incyte | $57.95 | 38.05% | $86 → $80 | Maintains | Neutral | Get Alert |
| 10/24/2022 | BNTX | Buy Now | BioNTech | $80.05 | 64.91% | $183 → $132 | Maintains | Neutral | Get Alert |
| 10/24/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $81.31 | 37.74% | $140 → $112 | Maintains | Overweight | Get Alert |
| 10/24/2022 | ALNY | Buy Now | Alnylam Pharmaceuticals | $246.81 | -18.97% | $204 → $200 | Maintains | Neutral | Get Alert |
| 09/14/2022 | IMCR | Buy Now | Immunocore Hldgs | $36.12 | 85.52% | $60 → $67 | Maintains | Overweight | Get Alert |
| 08/08/2022 | NKTR | Buy Now | Nektar Therapeutics | $1.25 | — | — | Downgrade | Neutral → Underweight | Get Alert |
| 05/24/2022 | UTHR | Buy Now | United Therapeutics | $311.13 | -23.51% | $225 → $238 | Maintains | Overweight | Get Alert |
| 05/06/2022 | AMRN | Buy Now | Amarin Corp | $0.70 | — | — | Downgrade | Neutral → Underweight | Get Alert |
| 05/05/2022 | ESPR | Buy Now | Esperion Therapeutics | $2.35 | — | — | Upgrade | Underweight → Neutral | Get Alert |
| 04/19/2022 | UTHR | Buy Now | United Therapeutics | $311.13 | -28.33% | $230 → $223 | Maintains | Overweight | Get Alert |
| 03/08/2022 | CARA | Buy Now | Cara Therapeutics | $0.27 | 7199.27% | $17 → $20 | Upgrade | Neutral → Overweight | Get Alert |
| 01/03/2022 | LABP | Buy Now | Landos Biopharma | — | — | $150 → $70 | Maintains | Neutral | Get Alert |
| 11/22/2021 | STOK | Buy Now | Stoke Therapeutics | $12.93 | 217.09% | — | Upgrade | Neutral → Overweight | Get Alert |
| 11/16/2021 | TCDA | Buy Now | Tricida | — | — | — | Upgrade | Underweight → Neutral | Get Alert |
